drugset / Trial / NCT03313336
A Study to Assess Therapeutic Equivalence Between Test EMLA Patch With Marketed EMLA Patch in Healthy Subjects.
RandomizedCrossoverDouble-blindSupportive care
Summary
A double-blind, randomized, 2-period, placebo-controlled, single-center, crossover study, efficacy study demonstrating the therapeutic equivalence of the test cellulose disc (matrix) in EMLA patch and the current commercial cellulose disc (matrix) in EMLA patch in healthy subjects.
Timeline
- Start
- 2017-10-30
- Primary completion
- 2017-11-09
- Completion
- 2017-11-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lidocaine | Other / unclassified | — | — |
| Comparator | prilocaine | Small molecule | — | — |
Indications
No indication recorded.